| | | | By Rachel Cohrs Mike Reddy for STAT The once-invincible organization PhRMA used to raise hell. Lately, however, the lobbying group's rhetoric is on mute. Read More | By Megan Molteni Kin Cheung/AP He Jiankui posted photos of himself sitting at a computer in a white office. "This is the first day for Jiankui He Lab," he wrote. Read More | By Lev Facher Adobe A heavyweight in addiction policy blasts the FDA's opioid mail-back proposal, while endorsing a funder's drug-disposal product. Read More | Sponsored Insight by Boston Scientific How can providers improve outcomes for their marginalized patients? Advocating for greater health equity has become the work of every self-respecting healthcare institution. Now, asks one scientist and health equity leader: What exactly is that work? What steps can we take toward meaningful change? The answers, she writes, is in the data. Her team is mining healthcare data in smart ways to pinpoint specific, actionable gaps – and, she suggests, the entire medtech industry is positioned to help. Read more. | By Vineeta Gupta Adobe The World Bank has rolled out The Pandemic Fund, a new financial intermediary fund, on an improbable and harmful timetable. Read More | |
No comments